BICAP tumor probe en el tratamiento paliativo de la estenosis esofágicas malignas
Background: BICAP tumor probe is a device that consists in an energy source and olives that deliver bipolar electricity. It can be used for the fulguration of esophageal tumors after endoscopic dilatation. Aim: To report the experience in the treatment of malignant esophageal stenoses using the BICA...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Lenguaje: | Spanish / Castilian |
Publicado: |
Sociedad Médica de Santiago
2000
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872000000500009 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:scielo:S0034-98872000000500009 |
---|---|
record_format |
dspace |
spelling |
oai:scielo:S0034-988720000005000092004-06-22BICAP tumor probe en el tratamiento paliativo de la estenosis esofágicas malignasCatán G,FelipeUribe M,MarioCarvajal H,CarlosCavalleri B,SilvanaPizarro I,FranciscoUribe L,Juan PabloUribe-Echevarría A,SebastiánLópez H,CristiánVenegas D,Lorena Esophagoscopy Esophageal neoplasms Esophageal stenosis Background: BICAP tumor probe is a device that consists in an energy source and olives that deliver bipolar electricity. It can be used for the fulguration of esophageal tumors after endoscopic dilatation. Aim: To report the experience in the treatment of malignant esophageal stenoses using the BICAP tumor probe. Patients and methods: Patients with advanced esophageal tumors in aphagia, that were not candidates for palliative surgery were included in this study. After endoscopic dilatation, the tumor was fulgurated with the BICAP tumor probe. Results: Twenty one patients (nine male, aged 43 to 91 years old) were treated with the device. A mean of 1.3 sessions with BICAP were necessary to obtain tumor permeabilization, which was obtained in all patients. One patient died of pneumonia 15 days after the procedure. All other patients were ingesting liquid or semisolid diets after two months of follow up. Mean survival after the procedure was 3.8 months. Conclusions: Electrical fulguration of esophageal tumors is a valid therapeutic alternative in aphagic patients. (Rev Méd Chile 2000; 128: 513-8)info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.128 n.5 20002000-05-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872000000500009es10.4067/S0034-98872000000500009 |
institution |
Scielo Chile |
collection |
Scielo Chile |
language |
Spanish / Castilian |
topic |
Esophagoscopy Esophageal neoplasms Esophageal stenosis |
spellingShingle |
Esophagoscopy Esophageal neoplasms Esophageal stenosis Catán G,Felipe Uribe M,Mario Carvajal H,Carlos Cavalleri B,Silvana Pizarro I,Francisco Uribe L,Juan Pablo Uribe-Echevarría A,Sebastián López H,Cristián Venegas D,Lorena BICAP tumor probe en el tratamiento paliativo de la estenosis esofágicas malignas |
description |
Background: BICAP tumor probe is a device that consists in an energy source and olives that deliver bipolar electricity. It can be used for the fulguration of esophageal tumors after endoscopic dilatation. Aim: To report the experience in the treatment of malignant esophageal stenoses using the BICAP tumor probe. Patients and methods: Patients with advanced esophageal tumors in aphagia, that were not candidates for palliative surgery were included in this study. After endoscopic dilatation, the tumor was fulgurated with the BICAP tumor probe. Results: Twenty one patients (nine male, aged 43 to 91 years old) were treated with the device. A mean of 1.3 sessions with BICAP were necessary to obtain tumor permeabilization, which was obtained in all patients. One patient died of pneumonia 15 days after the procedure. All other patients were ingesting liquid or semisolid diets after two months of follow up. Mean survival after the procedure was 3.8 months. Conclusions: Electrical fulguration of esophageal tumors is a valid therapeutic alternative in aphagic patients. (Rev Méd Chile 2000; 128: 513-8) |
author |
Catán G,Felipe Uribe M,Mario Carvajal H,Carlos Cavalleri B,Silvana Pizarro I,Francisco Uribe L,Juan Pablo Uribe-Echevarría A,Sebastián López H,Cristián Venegas D,Lorena |
author_facet |
Catán G,Felipe Uribe M,Mario Carvajal H,Carlos Cavalleri B,Silvana Pizarro I,Francisco Uribe L,Juan Pablo Uribe-Echevarría A,Sebastián López H,Cristián Venegas D,Lorena |
author_sort |
Catán G,Felipe |
title |
BICAP tumor probe en el tratamiento paliativo de la estenosis esofágicas malignas |
title_short |
BICAP tumor probe en el tratamiento paliativo de la estenosis esofágicas malignas |
title_full |
BICAP tumor probe en el tratamiento paliativo de la estenosis esofágicas malignas |
title_fullStr |
BICAP tumor probe en el tratamiento paliativo de la estenosis esofágicas malignas |
title_full_unstemmed |
BICAP tumor probe en el tratamiento paliativo de la estenosis esofágicas malignas |
title_sort |
bicap tumor probe en el tratamiento paliativo de la estenosis esofágicas malignas |
publisher |
Sociedad Médica de Santiago |
publishDate |
2000 |
url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872000000500009 |
work_keys_str_mv |
AT catangfelipe bicaptumorprobeeneltratamientopaliativodelaestenosisesofagicasmalignas AT uribemmario bicaptumorprobeeneltratamientopaliativodelaestenosisesofagicasmalignas AT carvajalhcarlos bicaptumorprobeeneltratamientopaliativodelaestenosisesofagicasmalignas AT cavalleribsilvana bicaptumorprobeeneltratamientopaliativodelaestenosisesofagicasmalignas AT pizarroifrancisco bicaptumorprobeeneltratamientopaliativodelaestenosisesofagicasmalignas AT uribeljuanpablo bicaptumorprobeeneltratamientopaliativodelaestenosisesofagicasmalignas AT uribeechevarriaasebastian bicaptumorprobeeneltratamientopaliativodelaestenosisesofagicasmalignas AT lopezhcristian bicaptumorprobeeneltratamientopaliativodelaestenosisesofagicasmalignas AT venegasdlorena bicaptumorprobeeneltratamientopaliativodelaestenosisesofagicasmalignas |
_version_ |
1718435917698433024 |